Gut microbiome dysbiosis and increased intestinal permeability in Australian children with islet autoimmunity and type 1 diabetes

This abstract has open access
Abstract Summary

Background : Intestinal epithelial integrity reflects a healthy gut microbiome and both may be compromised in type 1 diabetes (T1D). We aimed to characterise the gut microbiome, bacterial products and small intestinal permeability longitudinally in children with islet autoimmunity (IA) .

Methods : 88 children, median age 11.8 (IQR 8.1-13.3) years, were followed 6-monthly for a median of 13 (range 2-34) months. 18 had IA, 29 recent-onset T1D, and 41 were age- and gender-matched unrelated or sibling controls. Stool samples were collected into Omnigene OMR-200 tubes for 16S rRNA gene sequencing. Small intestinal permeability was measured by blood lactulose:rhamnose ratio (L/R), 90 minutes after drinking 5% lactulose/1% rhamnose solution. Short chain fatty acids (SCFA) were measured by gas chromatography. Diet was assessed with the Australian Child and Adolescent Food Frequency Questionnaire.

Results : Children with IA or T1D had differences in ? diversity and reduced anti-inflammatory bacteria. The Prevotella genus was less abundant in children with ? 2 islet antibodies (p<0.005) or T1D (p<0.005). Dietary fibre intake did not differ. T1D had higher L/R than sibling controls [mean difference (SE) = +2.58 (1.14); p=0.02]. Children with ? 2 autoantibodies who progressed to T1D (progressors) had lower ? diversity (observed richness) [-27.9 (11.9) mean difference (SE) p=0.02], different ? diversity (Adonis p=0.004), and higher L/R  than non-progressors [+7.18 (2.38) mean difference (SE) p=0.003].  Lower ? diversity related weakly to higher L/R in all groups [regression coefficient -0.09 (0.02) p; -0.13 (0.06) p=0.03 (InvSimpson)]. Lower observed richness also related to lower plasma acetate (regression coefficient 0.5 (0.23) p =0.03), but plasma acetate did not differ between T1D or ? 2 islet autoantibody and controls.

Conclusion : Children with IA or T1D have gut dysbiosis and increased intestinal permeability. Progressors from IA to T1D have gut dysbiosis and increased intestinal permeability compared with non-progressors.

Submission ID :
IDS22107
Submission Type
Abstract Topics
Robinson Research Institute, University of Adelaide , Australia
Robinson Research Institute
The Walter & Eliza Hall Institute of Medical Research, Melbourne, Australia
Harry Perkins Institute of Medical Research, Perth
Royal Melbourne Hospital, Vic, Australia
Royal Melbourne Hospital and Walter and Eliza Hall Institute
Childrens Hospital at Westmead, NSW, Australia
Robinson Research Institute, University of Adelaide , Australia
Robinson Research Institute, University of Adelaide , Australia
Walter and Eliza Hall Insitute of Medical Research, VIc, Australia
CSIRO, South Australia
University of Adelaide
The Walter and Eliza Hall Institute of Medical Research, Melbourne
University of Adelaide, Australia
Walter and Eliza Hall Institute

Abstracts With Same Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
2 visits

KEY DATES

Event dates:
Thursday 25 October - Monday 29 October 2018

Abstract submission deadline:
Monday 14 May 2018

Abstract notification:
July 2018

Early registration deadline:
Monday 3 September 2018

Registration deadline:
Monday 15 October 2018

Contact
British Society for Immunology
+44 (0)20 3019 5901
congress@immunology.org